Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure

Cancer Research

Volumn 57, Issue 4, 1997, Pages 646-650

  Oda, Hideaki ^a   Zhang, Shaomin ^a   Tsurutani, Naomi ^a   Shimizu, Seiichiro ^a   Nakatsuru, Yoko ^a   Aizawa, Shinichi ^b   Ishikawa, Takatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CARCINOGENESIS; CARCINOGENICITY; DNA DAMAGE; GENE LOSS; MOUSE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; CARCINOGENS; ETHYLNITROSOUREA; FEMALE; FETUS; GENE DELETION; GENES, P53; HUMANS; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; PREGNANCY;

EID: 0031045758     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
3. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
4. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Scordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
5. Lowe, S. W., Jacks, T., Housman, D., and Ruley, H. Abrogation of oncogene- associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA, 97: 2026-2030, 1994.
6. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
7. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
8. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
9. Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Weiseman, R. W., Pantazis, P., Giovanella, B. C., Tainsky, M. A., Bradley, A., and Donehower, L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8: 2457-2467, 1993.
10. Kemp, C. J., Donehower, L. A., Bradley, A., and Balman, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74: 813-822, 1993.
11. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5: 225-229, 1993.
12. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
13. Feason, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
14. Soussi, T., Legros, Y., Lubin, R., Ory, K., and Schlichtholz, B. Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57: 1-9, 1994.
15. Rasheed, B. K. A., McLendon, R. E., Herndon, J. E., Friedman, H. S., Friedmam, A. H., Bigner, D. D., and Bigner, S. H. Alterations of the TP53 gene in human gliomas. Cancer Res., 54: 1324-1330, 1994.
16. Lang, F. F., Miller, D. C. Koslow, M., and Newcomb, E. W. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg., 81: 427-436, 1994.
17. Boegler O., Huang, H-J. S., and Cavenee, W. K. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocyt es and facilitates their in vitro transformation. Cancer Res., 55: 2746-2751, 1995.
18. Yahanda, A. M., Bruner, J. M., Donehower, L. A., and Morrison, R. S. Astrocytes derived from p53-deficient mice provide a multislep in vitro model for development of malignant gliomas. Mol. Cell. Biol., 15: 4249-4259, 1995.
19. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Ikawa, Y., and Aizawa, S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 8: 3313-3322, 1993.
20. Hsu, S-M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
21. Oda, H., Nakatsuru, Y., and Ishikawa, T. Mutations fo the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res., 55: 658-662, 1995.
22. Bienz, B., Zakut-Houri, R., Givol, D., and Oren, M. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J., 3: 2179-2183, 1984.
23. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
24. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. Tumor spectrum analysis in p53-deficient mice. Curr. Biol., 4: 1-7, 1994.
25. Rehm, S., Ward, J. M., Have-Opbroek, A. A. W. T., Anderson, L. M., Singh, G., Kalal, S. L., and Rice, J. M. Mouse papillary lung tumors transplacentally induced by N-nitrosoethylurea: evidence for alveolar type II cell origin by comparative light microscopic, ullrastructural, and immunohistochemical studies. Cancer Res., 48: 148-160, 1988.
26. Peterson, D. L., Sheridan, P. J., and Brown, W. E., Jr. Animal models for brain tumors: historical perspectives and future directions. J. Neurosurg., 80: 865-876, 1994.
27. Brinster, R. L., Chen, H. Y., Messing, A., van Dyke, T., Levine, A. J., and Palmiter, R. D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell, 37: 367-379, 1984.
28. Palmiter, R. D., Chen, H. Y., Messing, A., and Brister, R. L. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature (Lond.), 376: 457-460, 1985.
29. Koestner, A., Swenberg, J. A., and Wechsler, W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am. J. Pathol., 63: 37-56, 1971.
30. Salcman, M. Glioblastoma and malignant astrocytoma. In: A. H. Kaye and E. R. Laws, Jr. (eds.), Brain Tumors: An Encyclopedic Approach, pp. 449-478. New York: Churchill Livingstone, 1995.
31. Sah, V. P., Attardi, D. L., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10: 175-180, 1995.
32. Nicol, C. J., Harrison, M. L., Laposa, R. R., Gimelshtein, I. L., and Wells, P. G. A teratologic suppressor role for p53 in benzo[a] pyrene-treated transgenic p53-deficient mice. Nat. Genet., 10: 181-187, 1995.
33. Schmid, P., Lorenz, A., Hameister, H., and Montenarh, M. Expression of p53 during mouse embryogenesis. Development (Camb.), 113: 857-865, 1991.
34. Louis, J. M., McFarland, V. M., May, P., and Mora, P. T. The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochem. Biophys. Acta., 950: 395-402, 1988.
35. Rogel, A., Popliker, M., Webb, C. G., and Oren, M. p53 cellular tumour antigen: analysis of mRNA levels in normal adult tissue, embryos, and tumours. Mol. Cell. Biol., 5: 2851-2855, 1985.